Diagnostics North East Conference 2020:

“Precision Medicine – Basic Science, Diagnostics and Therapeutics”

 30 April 2019

Venue: St James Park, Newcastle upon Tyne

Aim of the Conference

This conference will showcase the diagnostic resources and expertise available to support researchers, clinicians, and industry in developing and deploying new and innovative diagnostic technologies. The event will provide opportunities to meet with key experts and to discuss how they can support the development, evaluation and adoption of technologies into healthcare systems. In addition, delegates will receive information they need to partner and exploit the world-class resources available.

Register here

Thursday 30 April


09:00                     Registration, Exhibition and Networking


10:00 – 10:10     Welcome and Introduction

Dr Michael Wright, Chair of Diagnostics North East and Deputy Medical Director, The Newcastle upon Tyne Hospitals NHS Foundation Trust


Opening Keynote Speaker

10:10 – 10:40     TITLE TBC

Chris Molloy, Chief Executive Officer, Medicines Discovery Catapult


10:40 – 11:00     AI and Machine Learning

Professor Paul Watson, Director of the Digital Institute, Professor of Computer Science, Newcastle University 


11:00 – 11:15     Refreshments, Exhibition and Networking


11:15 – 12:30     Workshop Session 1

 

Diagnostic Laboratory Medicine and Pathology, Molecular Pathology Node

 

Tissue Repositories, Biobanks and CEPA

 

Evaluating Technologies, Newcastle In Vitro Diagnostics Co-operative (Newcastle MIC)

 

Patient and Public Involvement and Engagement in Research

Kasia Kurowska, Patient and Public Involvement and Engagement (PPIE) Manager, NIHR Newcastle Biomedical Research Centre


12:30 – 13:00     Regional Case Study

Professor Jelena Mann, Professor of Epigenetics, Fibrosis Research Group, Newcastle University


13:00 – 14:00     Lunch, Exhibition and Networking


14:15 – 15:30     Workshop Session 2

AHSN NENC and Cancer Network, Unmet need in Cancer Diagnostics

Russell Watkins, Commercial Director, AHSN NENC

CRN North East and North Cumbria and MedConnect North

Angela Birt, Industry Operations Manager, NIHR CRN NENC

Claire Graham, Research Operations Manager, NIHR CRN NENC

MDR and the UK Regulatory Landscape

Alison Bray, Medical Device Development, Northern Medical Physics and Clinical Engineering (NMPCE), The Newcastle upon Tyne Hospitals NHS Foundation Trust


15:30 – 15:45     Increasing Trade and Investment Opportunities for the North East

Katherine Forbes, Health and Life Sciences Lead, North East LEP


Closing Keynote Speaker

15:45 – 16:15     Pharmacogenomics and Precision Medicine  

Professor Sir Munir Pirmohamed, Professor, Molecular and Clinical Pharmacology, University of Liverpool


16:15 – 16:30     Q&A and Close of Conference

Dr Michael Wright, Chair of Diagnostics North East and Deputy Medical Director, The Newcastle upon Tyne Hospitals NHS Foundation Trust


 

Speaker Details

Chris Molloy, Chief Executive Officer, Medicines Discovery Catapult

Chris Molloy has a 30-year international board and executive career across a unique range of life sciences R&D disciplines.  He began in preclinical science and research management at Glaxo, where he was closely involved with the industrialisation of high throughput discovery, combining robotics, informatics and manufacturing theory.  He moved to Asia as COO of MerLion Pharmaceuticals, a Singaporean natural products biotech which became an award-winning multinational anti-infectives R&D company.  Chris then ran corporate development for the global informatics firm, idbs – now part of the Danaher group – achieving a Queens Award for Enterprise.  Chris spent three years as CEO of the RSA Group, the global life science executive search specialist, building high-value leadership teams.  In 2016 Chris became the founding CEO of Medicines Discovery Catapult - the national research technology facility supporting the sector by industrialising and driving the adoption of new R&D techniques for discovering medicines.

Chris is the non-executive chairman of Exploristics Ltd and NorthWest EHealth.  He chairs the IP Advisory Committee for the Association of Medical Research Charities, and the Industry Advisory Board for Manchester’s Biomedical Research Centre & Health Innovation Manchester.  Chris holds US and EU patents in HIV drug discovery; he is a Member of the Institute of Cancer Research and holds an honorary chair at the University of Manchester.

 

Professor Paul Watson, Director of the Digital Institute, Professor of Computer Science, Newcastle University

Paul Watson is Professor of Computer Science, Director of Newcastle Data and a Fellow of the Alan Turing Institute. He co-directs the EPSRC Centre for Doctoral Training in Cloud Computing for Big Data, and is PI for the £30M National Innovation Centre for Data. He has a long interest in using data analytics to transform healthcare, particularly by exploiting body-worn sensors: from 2009-15 he directed the £12M RCUK Digital Economy Hub on Social Inclusion through the Digital Economy which focussed on using advanced computing technologies to transform the lives of older people and those with disabilities.

Professor Watson is a Fellow of the Royal Academy of Engineering (where he sits on their Diversity and Inclusion Committee), a Fellow of the British Computer Society, a Chartered Engineer and a member of the DfT Science Advisory Committee. He received the 2014 Jim Gray eScience Award.

 

Professor Jelena Mann, Professor of Epigenetics, Fibrosis Research Group, Newcastle University

 

 

 

Katherine Forbes, Health and Life Sciences Lead, North East LEP

Katherine, a graduate returner to the North East, whose career spans the private, public and HE sectors, brings with her over 20 years working across a range of economic development and policy and partnership roles, with universities and health sector, developing and delivering ambitious projects for the North East.

Katherine joined the North East LEP in September 2019. As sector lead for Health and Life Sciences, Katherine, a graduate returner to the North East, whose career spans the private, public and HE sectors.

The North East Local Enterprise Partnership (LEP) is a public, private, and education sector partnership that covers Durham, Gateshead, Newcastle, Northumberland, North Tyneside, South Tyneside and Sunderland local authority areas. As a senior member of the executive team at the LEP, Katherine leads on positioning the North East as a leader in Health and Life Sciences- developing a growth strategy for the sector, facilitating and supporting the development and alignment of key programmes to ensure the economic conditions are right to enable the health and life sciences sector to thrive and play its part in strengthening the region’s economy.

Katherine is also a Trustee of a local community charity based in North Tyneside.

 

Professor Sir Munir Pirmohamed, Professor, Molecular and Clinical Pharmacology, University of Liverpool

Professor Sir Munir Pirmohamed is currently David Weatherall Chair in Medicine at the University of Liverpool, and a Consultant Physician at the Royal Liverpool University Hospital. He also holds the only NHS Chair of Pharmacogenetics in the UK, and is Director of the M.R.C. Centre for Drug Safety Sciences, and Director of the Wolfson Centre for Personalised Medicine. He was awarded a Knights Bachelor in the Queen’s Birthday Honours list in 2015. He is currently President of British Pharmacological Society and an inaugural NIHR Senior Investigator, and Fellow of the Academy of Medical Sciences in the UK. He is a Commissioner on Human Medicines. He is also a member of the MRC Governing Council and has also recently been appointed as a non-executive director of NHS England. His research focuses on personalised medicine in order to optimise drug efficacy and minimise toxicity, move discoveries from the lab to the clinic, and from clinic to application.